INmuneBIO Company
INmune Bio, Inc. is developing therapies that harness the patients immune system to treat cancer.
%20.jpg)
Total Funding:
$48.2M
Headquarters:
La Jolla, California, United States
Funding Status:
IPO
Employee Number:
11-50
Estimated Revenue:
Less than $1M
Last Funding Type:
Post-IPO Equity
Technology:
Data-driven Technologies
Investors Number:
2
Founded Date:
2015
Industry:
PharmTech